110 related articles for article (PubMed ID: 9694007)
1. cAMP-dependent phosphorylation system after short and long-term administration of moclobemide.
Mori S; Zanardi R; Popoli M; Garbini S; Brunello N; Smeraldi E; Racagni G; Perez J
J Psychiatr Res; 1998; 32(2):111-5. PubMed ID: 9694007
[TBL] [Abstract][Full Text] [Related]
2. The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine.
Lavian G; Finberg JP; Youdim MB
Clin Neuropharmacol; 1993; 16 Suppl 2():S1-7. PubMed ID: 8313392
[TBL] [Abstract][Full Text] [Related]
3. A novel diol-derivative of chalcone produced by bioconversion, 3-(2,3-dihydroxyphenyl)-1-phenylpropan-1-one, activates PKA/MEK/ERK signaling and antagonizes Abeta-inhibition of the cascade in cultured rat CNS neurons.
Al Rahim M; Nakajima A; Misawa N; Shindo K; Adachi K; Shizuri Y; Ohizumi Y; Yamakuni T
Eur J Pharmacol; 2008 Dec; 600(1-3):10-7. PubMed ID: 18948095
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the new MAO-A inhibitors moclobemide, brofaromine and toloxatone with tranylcypromine in an animal experiment: significance for clinical practice].
Da Prada M; Keller HH; Kettler R
Psychiatr Prax; 1989 Aug; 16 Suppl 1():18-24. PubMed ID: 2587673
[TBL] [Abstract][Full Text] [Related]
5. Moclobemide effects on prolactin plasma levels in healthy individuals: the hormonal increase induced by a single dose is maintained during a 4-week period of drug intake.
Juruena MF; Pires ML; Calil HM
Int Clin Psychopharmacol; 1997 Nov; 12(6):317-21. PubMed ID: 9547133
[TBL] [Abstract][Full Text] [Related]
6. Pre-clinical pharmacology of moclobemide. A review of published studies.
Burkard WP; Da Prada M; Keller HH; Kettler R; Haefely W
Br J Psychiatry Suppl; 1989 Oct; (6):84-8. PubMed ID: 2695131
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
Da Prada M; Kettler R; Keller HH; Burkard WP; Muggli-Maniglio D; Haefely WE
J Pharmacol Exp Ther; 1989 Jan; 248(1):400-14. PubMed ID: 2783611
[TBL] [Abstract][Full Text] [Related]
8. DSM-RX78, a new phosphodiesterase inhibitor, suppresses superoxide anion production in activated human neutrophils and attenuates hemorrhagic shock-induced lung injury in rats.
Yu HP; Hsieh PW; Chang YJ; Chung PJ; Kuo LM; Hwang TL
Biochem Pharmacol; 2009 Oct; 78(8):983-92. PubMed ID: 19540209
[TBL] [Abstract][Full Text] [Related]
9. Light-dark phase differences in behavioral effects of moclobemide in rats.
Górka Z; Zajaczkowski W
Pol J Pharmacol Pharm; 1991; 43(3):177-86. PubMed ID: 1961692
[TBL] [Abstract][Full Text] [Related]
10. Anxiolytic and memory improving effects of moclobemide.
Nowakowska E; Chodera A; Kus K; Rybakowski J
Arzneimittelforschung; 1998 Jun; 48(6):625-8. PubMed ID: 9689417
[TBL] [Abstract][Full Text] [Related]
11. Interplay of PI3K and cAMP/PKA signaling, and rapamycin-hypersensitivity in TGFbeta1 enhancement of FSH-stimulated steroidogenesis in rat ovarian granulosa cells.
Chen YJ; Hsiao PW; Lee MT; Mason JI; Ke FC; Hwang JJ
J Endocrinol; 2007 Feb; 192(2):405-19. PubMed ID: 17283241
[TBL] [Abstract][Full Text] [Related]
12. [Changes of AC/cAMP system and phosphorylation regulation of adenylate cyclase activity in brain regions from morphine-dependent mice].
Fang F; Wang Q; Cao Q; Liu J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):14-9. PubMed ID: 12903486
[TBL] [Abstract][Full Text] [Related]
13. Noradrenaline reduces the ATP-stimulated phosphorylation of p38 MAP kinase via beta-adrenergic receptors-cAMP-protein kinase A-dependent mechanism in cultured rat spinal microglia.
Morioka N; Tanabe H; Inoue A; Dohi T; Nakata Y
Neurochem Int; 2009 Sep; 55(4):226-34. PubMed ID: 19524113
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic ethanol intake and its withdrawal on the expression and phosphorylation of the creb gene transcription factor in rat cortex.
Pandey SC; Roy A; Mittal N
J Pharmacol Exp Ther; 2001 Mar; 296(3):857-68. PubMed ID: 11181917
[TBL] [Abstract][Full Text] [Related]
15. Modulation of NMDA receptor function by cyclic AMP in cerebellar neurones in culture.
Llansola M; Sánchez-Pérez AM; Montoliu C; Felipo V
J Neurochem; 2004 Nov; 91(3):591-9. PubMed ID: 15485490
[TBL] [Abstract][Full Text] [Related]
16. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin.
Kato M; Katayama T; Iwata H; Yamamura M; Matsuoka Y; Narita H
J Pharmacol Exp Ther; 1998 Mar; 284(3):983-90. PubMed ID: 9495858
[TBL] [Abstract][Full Text] [Related]
17. [Selective inhibition of monoamine oxidase in bovine brain by befol and moclobemide].
Moskvitina TA; Gankina EM; Val'dman AV
Vopr Med Khim; 1991; 37(2):49-51. PubMed ID: 1897195
[TBL] [Abstract][Full Text] [Related]
18. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
Nesterova MV; Cho-Chung YS
Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549
[TBL] [Abstract][Full Text] [Related]
19. The cheese effect and new reversible MAO-A inhibitors. Proceedings of the round table of the International Conference on New Directions in Affective Disorders, Jerusalem, April 5-9, 1987.
J Neural Transm Suppl; 1988; 26():1-136. PubMed ID: 3162947
[No Abstract] [Full Text] [Related]
20. Antidepressant-induced increase in high-affinity rolipram binding sites in rat brain: dependence on noradrenergic and serotonergic function.
Zhao Y; Zhang HT; O'Donnell JM
J Pharmacol Exp Ther; 2003 Oct; 307(1):246-53. PubMed ID: 12954819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
